Navigation Links
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
Date:10/2/2007

PITTSBURGH, Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Rajiv Malik as Executive Vice President in charge of Global Technical Operations. Mr. Malik has served in a similar capacity for Mylan since the Company acquired a controlling stake in Matrix Laboratories Limited (Matrix), where he is Chief Executive Officer, in January 2007.

As Head of Global Technical Operations, Mr. Malik will oversee the Company's global research and development (R&D) centers and manufacturing and distribution units, with responsibility for enhancing and rationalizing Mylan's global supply chain and expanded product pipeline, as well as leveraging Matrix, one of the world's largest suppliers of active pharmaceutical ingredients, across the enlarged company.

Mr. Malik has worked more than 24 years in the global generic pharmaceutical industry. In addition to his role at Mylan, Mr. Malik currently serves as Managing Director and Chief Executive Officer of Matrix. Prior to joining Matrix in 2005, he was Head of Global Development and Regulatory at Sandoz. He started his career in R&D at Ranbaxy Laboratories, rising to Head of Generics R&D.

Mylan's Vice Chairman and CEO Robert J. Coury commented, "Rajiv has been an invaluable addition to the Mylan management team since joining us in January. Since the close of the Matrix transaction, he has truly proven his capabilities and has been instrumental in the successful integration of Matrix. Rajiv has built an outstanding operational infrastructure that will allow us to capitalize on the efficiencies, synergies and sourcing opportunities we see from bringing together all three companies."

Mr. Malik earned his master's degree in pharmaceutical technology from Punjab University and has more than 60 process patents to his credit.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. Where Burnt Out Executives De-stress in Natures Lap
5. Asian Business Executives Urged to Be Eco-friendly
6. BMA Welcomes Scottish Executives Move to Raise the Purchase Age of Cigarettes
7. Skin Cancer Research To Go Global
8. Dementia - a global problem
9. Obesity a global problem
10. Suggestions to reduce global heart disease burden
11. Drop in global deaths from measles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology: